Richard Kerensky, MD
Interventional Cardiology · Gainesville, FLNPI 1649248311
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.7%), food and beverage and education — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Abbott at 55.5% of the total. Reporting peaked in 2019 at $3,058 and has fallen 93.3% since, to $204 in 2025. That places this record below the midpoint for interventional cardiology clinicians in FL, where the typical reported total is $7,973.
Across 60 payments — averaging $120.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$1K
- Boston Scientific$424
- Shockwave Medical, Inc$282
- Teleflex LLC$269
- Abiomed$254
- plus $802 from 6 others
What the payments were for
- Travel & lodging$3,96555%
- Food & beverage$3,24245%
- Education$431%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 17 | $4,022 |
| Medtronic(2 entities) | 12 | $1,196 |
| Boston Scientific | 9 | $424 |
| Shockwave Medical, Inc | 5 | $282 |
| Teleflex LLC | 2 | $269 |
| Abiomed | 4 | $254 |
| Amgen | 2 | $220 |
| Recor Medical Inc | 2 | $199 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $182 |
| Corindus Inc. | 1 | $163 |
| Procyrion, Inc. | 1 | $21 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,249 in reported general payments places this provider in the 45th percentile of 623 interventional cardiology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 141 | $141,613 |
| EliquisApixaban | 76 | $84,246 |
| EntrestoSacubitril/Valsartan | 47 | $49,383 |
| Repatha SyringeEvolocumab | 21 | $26,932 |
| JardianceEmpagliflozin | 11 | $18,705 |
| XareltoRivaroxaban | 11 | $9,045 |
| Ezetimibe | 297 | $7,260 |
| Atorvastatin Calcium | 343 | $3,410 |
| Rosuvastatin Calcium | 198 | $2,889 |
| Metoprolol Succinate | 168 | $1,862 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 48 | $1,718 |
| Amlodipine Besylate | 167 | $1,155 |
| Prasugrel Hcl | 14 | $1,146 |
| ClopidogrelClopidogrel Bisulfate | 114 | $1,073 |
| Nitroglycerin | 37 | $786 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $16 | $49,38347 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 623 interventional cardiology providers in Florida.
Other interventional cardiology in Gainesville
- Arthur LeeGainesville$1.8M
- Matheen KhuddusGainesville$164K
- Christopher CaputoGainesville$67K
- Santhosh MathewsBradenton$1.4M
- Siddharth WayangankarJacksonville$1.2M
- Patrick CambierTrinity$901K
- Zahid AminOrlando$635K
- Rohit AminPensacola$560K
- Eduardo de MarchenaMiami$498K
- Dominick AngiolilloJacksonville$387K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.